Approaches to Managing Benzodiazepines (for BCACP credit)

Activity Preview

This activity is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). It is part of the APhA professional development program for BCACP recertification approved by BPS.

Long-term use of benzodiazepines has been known to produce complications related to discontinuation, withdrawal symptoms, increased risk of accidental overdose when combined with other central nervous system depressants, persistence of benzodiazepine related side effects, physical dependence, and benzodiazepines use disorders.Though benzodiazepines remain first-line treatments for acute alcohol withdrawal and may be used as acute anticonvulsants, they should generally be avoided for anxiety disorders, panic disorder, and insomnia. Other effective treatment options with superior safety profiles should be utilized when possible for these conditions. If a benzodiazepine is used, it should be limited to 2–4 weeks.

Learning Objectives

At the completion of this application-based activity, participants will be able to:

    1. Identify patients at risk for complications and adverse events related to use of a benzodiazepine.
    2. Discuss appropriate strategies to tapering benzodiazepines.
    3. Recognize benzodiazepine withdrawal symptoms and other potential complications related to tapering.
    4. Describe appropriate uses for a benzodiazepine. 

Activity type: Application-based

Target Audience: Pharmacists 

Learning Level: 2

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 2.0 contact hour of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-298-H01-P

To obtain credit for completing Approaches to Managing Benzodiazepines, read the article, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.  

Initial release date: December 20, 2019

Expiration date: December 20, 2022

Development

Approaches to Managing Benzodiazepines is an online educational activity for pharmacists developed by the American Pharmacists Association.  

Disclosures

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 

Fee

There is a $40 member fee and a $70 nonmember fee to participate in this activity which includes the recertification exam. No refunds. 

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-19-298-H01-P 0.2 CEUs December 20, 2019 - December 20, 2022
0202-0000-19-298-H01-P 2 Hours December 20, 2019 - December 20, 2022